B. Riley Securities Downgrades Anterix to Neutral, Raises Price Target to $69

Benzinga Newsdesk www.benzinga.com Negative 78.6%

Neg 78.6% Neu 0% Pos 0%

B. Riley Securities analyst Mike Crawford downgrades Anterix (NASDAQ:ATEX) from Buy to Neutral and raises the price target from $44 to $69.